Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Armin Roessler is active.

Publication


Featured researches published by Armin Roessler.


Journal of Organic Chemistry | 2011

Direct, metal-free amination of heterocyclic amides/ureas with NH-heterocycles and N-substituted anilines in POCl3.

Xiaohu Deng; Armin Roessler; Ivana Brdar; Roger Faessler; Jiejun Wu; Zachary S. Sales; Neelakandha S. Mani

A POCl(3)-mediated, direct amination reaction of heterocyclic amides/ureas with NH-heterocycles or N-substituted anilines is described. Compared to the existing methods, this operationally simple protocol provides unique reactivity and functional group compatibility because of the metal-free, acidic reaction conditions. The yields are generally excellent.


Organic Preparations and Procedures International | 2010

An Improved Non-chromatographic Scale-up Synthesis of a New 1,6,7,8-Substituted-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid as a Potent Bacterial Topoisomerase Inhibitor

Xun Li; Scott Youells; Ronald K. Russell; Armin Roessler; Tobias Schmid; Roger Faessler; Michele A. Weidner-Wells; Eugene B. Grant; Mark J. Macielag

7-[4-(2-Amino-1-chloroethylidene)piperidin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4oxo-1,4-dihydroquinoline-3-carboxylic acid (10) is a potent bacterial topoisomerase inhibitor. In vitro, compound 10 is two-fold more potent than gemifloxacin when tested against ciprofloxacin-resistant Streptococcus pneumoniae clinical isolates (MIC90 = 1 μg/mL); it is also more potent than ciprofloxacin and gemifloxacin when tested against a collection of methicillin-resistant Staphylococcus aureus (MIC90 = 2 μg/mL) and coagulase-negative staphylococci isolates (MIC90 = 1 μg/mL).1,2 In order to prepare 100 g of compound 10 to facilitate in vivo investigation, it was decided to attempt to improve some of the steps of the original discovery medicinal chemistry (Discovery) route, an eight-step convergent synthesis with merely 6% overall yield of 10,1,2 and address the scale up issues that were identified in the following steps: first, the high exothermicity of the use of sodium hydride (NaH) to generate triethyl 2-chloro-2phosphonoacetate anion in the Horner-Wadsworth-Emmons reaction and its quenching (Step 1, Schemes 1), second, the reduction of ester 2 using DIBALH resulted in a 44% yield of alcohol 3 after chromatography (Step 2, Schemes 1), third, the product 4 of Mitsunobu reaction also required chromatographic purification (Step 3, Schemes 1), fourth the preparation of difluoroborate ester 7 required a large excess (11.9 equiv) of borontrifluoride etherate and extended reaction times (48–72 h), but gave only moderate to fair yields (50–78%) of 7 by precipitation of the crude product with diethyl ether


Organic Process Research & Development | 2003

A practical synthesis of the platelet fibrinogen antagonist, elarofiban

Judith H. Cohen; Mary Ellen Bos; Sergio Cesco-Cancian; Bruce D. Harris; John T. Hortenstine; Michael Justus; Cynthia A. Maryanoff; John E. Mills; Stefan Muller; Armin Roessler; Lorraine Scott; Kirk L. Sorgi; Frank J. Villani; Robin R. H. Webster; Christian Weh


Journal of Organic Chemistry | 2007

Methodology for the Preparation of 2-Argininylbenzothiazole

Birdella Kenney; Michael Breslav; Rosie Chang; Roland Glaser; Bruce D. Harris; Cynthia A. Maryanoff; John E. Mills; Armin Roessler; Brigitte Segmuller; Frank J. Villani


Archive | 2008

One-Pot Condensation-Reduction Methods for Preparing Substituted Allylic Alcohols

Michael Reuman; Roger Faessler; Armin Roessler; Kirk L. Sorgi; Xun Li; Jeffrey S. Grimm


Archive | 2004

Process for preparing peptidyl heterocyclic ketone derivatives

Michael Breslav; Bruce D. Harris; Birdella Kenney; Thomas Maier; Armin Roessler; Frank J. Villani; Ulrich Weigl; Fan Zhang-Plasket; Hua Zhong


Archive | 2004

PEPTIDYL HETEROCYCLIC KETONE DERIVATIVES AND PREPARATION PROCESSES

Michael Breslav; Bruce D. Harris; Birdella Kenney; Armin Roessler; Frank J. Villani; Ulrich Weigl; Fan Zhang-Plasket; Hua Zhong; Thomas Maier


Archive | 2008

SALES DE 3-(3-AMINO-2-(R)-HIDROXI-PROPIL)-1-(4-FLUORO-FENIL)-8-(8- METIL-NAFTALEN-1-ILMETIL)-1,2,8-TRIANZA-ESPIRO[4.5]DECAN-4-ONA

Steven J. Mehrman; Armin Roessler; Roger Faessler; Frank J. Villani; Hegyi Jean-Francois Alexandre Lucas


Archive | 2007

Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one

Steven J. Mehrman; Armin Roessler; Roger Faessler; Frank J. Villani; Jean François Alexandre Lucas Hegyi


Archive | 2006

Neue lysinsalze von 4-((phenoxyalkyl)thio)phenoxyessigsäurederivaten

Ahmed F. Abdel-Magid; Steven J. Mehrman; Armin Roessler

Collaboration


Dive into the Armin Roessler's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruce D. Harris

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Birdella Kenney

University of North Carolina at Charlotte

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hua Zhong

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge